HAVCR2 and COVID-19: In COVID-19 patients, one study demonstrated that PD-1 and Tim-3 were increased in expression as COVID-19 symptoms progressed while another found increased PD-1 expression in patients with active disease compared to patients who had recovered from mild disease (27, 39).